Documentos de Silva-Abreu M. | REDI

Regresar

Mostrando 7 resultados de: 7

Filtros aplicados

Objetivos de Desarrollo Sostenible: "ODS 9: Industria, innovación e infraestructura"

Subtipo de publicación

Publisher

Pharmaceuticals(2)

Pharmaceutics(2)

European Journal of Pharmaceutical Sciences(1)

Nanomedicine: Nanotechnology, Biology, and Medicine(1)

Área temáticas

Farmacología y terapéutica(7)

Enfermedades(3)

Cirugía y especialidades médicas afines(1)

Fisiología humana(1)

Área de conocimiento

Farmacología(5)

Descubrimiento de fármacos(2)

Ciencia de materiales(1)

Objetivos de Desarrollo Sostenible

ODS 10: Reducción de las desigualdades(7)

ODS 3: Salud y bienestar(7)

Año de Publicación

Origen

Palabras Claves

Pioglitazone(4)

NANOEMULSIÓN(3)

Alzheimer's disease(2)

Alzheimer’s disease(1)

Comparative study of Ex Vivo transmucosal permeation of pioglitazone nanoparticles for the treatment of Alzheimer's disease

Abstract: Pioglitazone has been reported in the literature to have a substantial role in the improvement of ov

Palabras claves:

Alzheimer's disease, Nanoparticles, Pioglitazone, PLGA-PEG, Transmucosal permeations

Calpena A.C., Espina M., García M.L., Halbaut L., Lupe Carolina Espinoza, Silva-Abreu M.

Apremilast microemulsion as topical therapy for local inflammation: Design, characterization and efficacy evaluation

Abstract: Apremilast (APR) is a selective phosphodiesterase 4 inhibitor administered orally in the treatment o

Palabras claves:

Apremilast, inflammation, Microemulsion, Phosphodiesterase 4, Skin Diseases

Badia J., Calpena A.C., Díaz-Garrido N., Fábrega M.J., Halbaut L., Lupe Carolina Espinoza, Paulo Sarango-Granda, Rodríguez-Lagunas M.J., Silva-Abreu M.

Formulation strategies to improve nose-to-brain delivery of donepezil

Abstract: Donepezil (DPZ) is widely used in the treatment of Alzheimer’s disease in tablet form for oral admin

Palabras claves:

Alzheimer’s disease, Donepezil, Mucoadhesion, NANOEMULSIÓN, Nose-to-brain, Pluronic F-127

Calpena A.C., Cañas M.A., Clares-Naveros B., Halbaut L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.

Quality by Design of Pranoprofen Loaded Nanostructured Lipid Carriers and Their Ex Vivo Evaluation in Different Mucosae and Ocular Tissues

Abstract: Transmucosal delivery is commonly used to prevent or treat local diseases. Pranoprofen is an anti-in

Palabras claves:

design of experiment, nanostructured lipid carriers, ophthalmic tissues, permeation, porcine mucous membrane

Abrego G., Calpena A.C., Lupe Carolina Espinoza, Mallandrich M., Pesantez-Narvaez J., Rincón M., Silva-Abreu M., Sosa L.

Nanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases

Abstract: Pioglitazone (PGZ)is a peroxisome proliferator-activated receptor agonist. Its role in the inflammat

Palabras claves:

anti-inflammatory activity, cytokines, NANOEMULSIÓN, Pioglitazone, Skin disorders

Calpena A.C., Clares-Naveros B., Fábrega M.J., Garduño-Ramírez M.L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.

Thiazolidinedione as an alternative to facilitate oral administration in geriatric patients with Alzheimer's disease

Abstract: Pioglitazone (PGZ) is a member of the thiazolidinedione (TZDs) family of drugs and it is primarily u

Palabras claves:

Alzheimer's disease, Geriatric patients, Mucosal permeation, Oral administration, Pioglitazone, Thiazolidinediones

Calpena A.C., Espina M., García M.L., Gonzalez-Pizarro R., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.

Topical pioglitazone nanoformulation for the treatment of atopic dermatitis: Design, characterization and efficacy in hairless mouse model

Abstract: Pioglitazone (PGZ) is a drug used to treat type 2 diabetes mellitus that has been reported to show a

Palabras claves:

Atopic dermatitis, NANOEMULSIÓN, Pioglitazone, Pluronic F127

Badia J., Calpena A.C., Clares-Naveros B., Domènech Ò., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M., Vera-García R.